Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05470036 · ClinicalTrials.gov registry record · NA
Improving Germline Testing in At-Risk Patients With Prostate Cancer
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT05470036: Completed NA study, sponsored by University of California, San Diego.
NCT05470036 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05470036, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
A quality improvement initiative to improve rates of germline testing among men with prostate cancer through the use of an in-clinic educational session.
Primary Outcome
Germline genetic testing among adult prostate cancer patients who are recommended to receive germline testing per NCCN guidelines.
Interventions
- BEHAVIORAL Educational intervention.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2022-09-27 |
| Est. Completion | 2025-09-01 |
| Phase | NA |
What the finished NCT05470036 record still lists
NCT05470036 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Educational intervention. is the first listed.
NCT05470036 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05470036 about?
NCT05470036 is a clinical study titled "Improving Germline Testing in At-Risk Patients With Prostate Cancer". A quality improvement initiative to improve rates of germline testing among men with prostate cancer through the use of an in-clinic educational session.
What is the current status of trial NCT05470036?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2022-09-27. Estimated completion is 2025-09-01.
What interventions are being tested in trial NCT05470036?
The interventions under investigation include: Educational intervention. (BEHAVIORAL).
Who is sponsoring clinical trial NCT05470036?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05470036's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI